跳至主要内容
临床试验/NCT01810029
NCT01810029Unknown2 期

A Randomized Controlled Trial of Stress Reduction in the Secondary Prevention of Coronary Heart Disease in African Americans

Maharishi International University1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2009年10月最近更新:
适应症

试验速览

阶段
2 期
入组人数
56
试验地点
1
主要终点
coronary blood flow as measured by PET

研究概览

简要总结

The overall hypothesis of this study is that a cardiac rehabilitation program with meditation will be more effective than cardiac rehabilitation alone in improving blood flow through the diseased coronary arteries in African Americans. For this purpose, 56 African American men and women with coronary heart disease will be randomly assigned either to standard cardiac rehabilitation plus the Transcendental Meditation program or to standard cardiac rehabilitation alone. The treatment period will be 12 weeks in length.

详细描述

The overall objective of this study is to conduct a randomized controlled trial to determine the efficacy of cardiac rehabilitation with and without a structured, standardized, and validated stress reduction component in the secondary prevention of coronary heart disease (CHD) in African Americans. In this phase II trial, 56 African American men and women with established CHD will be randomly allocated either to standard cardiac rehabilitation with formal stress reduction training using the Transcendental Meditation program or to standard cardiac rehabilitation alone. The intervention period will be 12 weeks. At baseline and posttest, subjects will be tested by quantitative Positron Emission Tomography (PET) for myocardial perfusion and ischemia. Secondary outcomes comprise physiological, behavioral and psychosocial risk factors for CHD. The field site will be Columbia University Medical Center and the coordinating center will be MUMRI-Center for Natural Medicine and Prevention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Male or female
  • Age: No limitations
  • CHD documented by medical history of at least one of the following: a.acute myocardial infarction (MI) within the preceding 12 months b.coronary artery bypass surgery (CABG) c. percutaneous coronary intervention (PCI, PTCA)d. chronic stable angina
  • Written informed consent

排除标准

  • noncardiac life threatening illness
  • Severe cognitive impairment or physical disability
  • History of major psychiatric disorder, i.e. psychosis, dementia, or substance abuse disorder within the past year.
  • Left ventricular ejection fraction less than 40%
  • Conditions that may be a contraindications to PET perfusion imaging with adenosine stress testing, including unstable angina or myocardial infarction in the past week, aortic stenosis, uncontrolled hypertension, uncontrolled atrial or ventricular arrhythmias, second-degree or higher atrio-ventricular block in the absence of a functioning pacemaker, baseline hypotension (systolic blood pressure < 90 mm Hg), severe obstructive lung disease or decompensated heart failure.

结局指标

主要结局

coronary blood flow as measured by PET

时间窗: 12 weeks

次要结局

  • blood pressure, behavioral risk factors (diet, exercise, substance use) and psychosocial stress factors (depression, social support, general well-being)(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Schneider, MD

Director, Center for Natural Medicine and Prevention

Maharishi International University

研究点 (1)

Loading locations...

相似试验

A Trial of Stress Reduction in the Secondary... | 临床试验